Document Detail

Paradoxical endogenous synthesis of a coronary dilating substance from arachidonate.
MedLine Citation:
PMID:  968049     Owner:  NLM     Status:  MEDLINE    
Isolated bovine, canine, and human coronary arteries exhibited dose dependent contractions to prostaglandin (PG) E2 and F2alpha (50 ng/ml to 10mug/ml). The ED50 value for both PGE2 and PGF2alpha was 500 ng/ml in the bovine and human coronary arteries. Paradoxically, although PGE2 and gf2alpha are vasoconstrictors, administration of their precursor, arachidonate (100 ng/ml to 10 mug/ml) caused relaxation of the bovine, canine and human coronary arteries. This observation suggests that arachidonate is not being converted by the coronary PG synthetase to PGE2 or PGF2alpha. However, the arachidonate induced coronary relaxation was inhibited by pretreatment with PG synthetase inhibitors, indomethacin, meclofenemate and aspirin. Indomethacin addition to the strips previously relaxed by arachidonate caused contraction. In contrast to other PGs (E2 and F2alpha), PGE1 (10 ng/ml to 10 mug/ml) caused dose dependent relaxation of the bovine coronary arteries (ED50 = 100 ng/ml). Indomethacin induced further relaxation of the blood vessels previously relaxed by PGE1. Since PGE1 cannot arise from arachidonate, the arachidonate coronary dilation and reversal by indomethacin must be independent of PGE1 formation. Linolenate (100 ng/ml to 10 mug/ml) and oleate (100 ng/ml to 10 mug/ml) also caused relaxation of the bovine coronary blood vessels both before and after indomethacin, thereby eliminating a direct non-specific fatty acid effect as the cause of the arachidonate relaxation. These results suggest that in isolated coronaries, arachidonate undergoes a novel conversion, possibly by PG synthetase, to a dilating substance which exerts different contractile effects than exogenously administered PGE2, PGF2alpha and PGE1.
P S Kulkarni; R Roberts; P Needleman
Related Documents :
16116339 - Hemodynamic effect of intracoronary administration of levosimendan in the anesthetized ...
15989539 - Cellular mechanisms for the treatment of chronic heart failure: the nitric oxide- and a...
17669949 - Endothelial function after prolonged coronary artery oxygen persufflation in a rabbit m...
3708649 - Comparison of the effects of the ionophore salinomycin and adrenaline on the haemodynam...
10094179 - Flow-dependent vasodilation in the coronary circulation: alterations in diseased states.
2360689 - Vascular reactivity of the coronary artery in rainbow trout (oncorhynchus mykiss).
25131169 - The carbomedics supra-annular top hat valve improves long-term left ventricular mass re...
21383339 - Efficacy of metabolic modulators in ischemic heart disease: an overview.
8348819 - Accelerated cholesterol synthesis in the monocytes of young myocardial infarction survi...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Prostaglandins     Volume:  12     ISSN:  0090-6980     ISO Abbreviation:  Prostaglandins     Publication Date:  1976 Sep 
Date Detail:
Created Date:  1976-12-01     Completed Date:  1976-12-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0320271     Medline TA:  Prostaglandins     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  337-53     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arachidonic Acids / pharmacology*
Arteries / drug effects
Aspirin / pharmacology
Coronary Vessels / drug effects*
Dose-Response Relationship, Drug
Drug Interactions
Indomethacin / pharmacology
Linolenic Acids / pharmacology
Meclofenamic Acid / pharmacology
Muscle Contraction / drug effects
Muscle, Smooth / drug effects
Oleic Acids / pharmacology
Prostaglandins E / administration & dosage,  pharmacology*
Prostaglandins F / administration & dosage,  pharmacology*
Vasodilator Agents / biosynthesis*
Reg. No./Substance:
0/Arachidonic Acids; 0/Linolenic Acids; 0/Oleic Acids; 0/Prostaglandins E; 0/Prostaglandins F; 0/Vasodilator Agents; 50-78-2/Aspirin; 53-86-1/Indomethacin; 644-62-2/Meclofenamic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prostaglandin endoperoxide and thromboxane generating systems and their selective inhibition.
Next Document:  Studies on the effects of prostaglandins E1, E2, A1, and A2 on the dustus arteriosus of swine in viv...